| |
| |
|
| Insider
Information: |
Cooper Graham K |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
142,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$379,175 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,500 |
|
|
| Total
Value |
$379,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orexigen Therapeutics, Inc. |
OREX |
CFO and Treasurer |
2009-12-21 |
0 |
2007-11-20 |
0 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
Chief Financial Officer |
2015-08-27 |
0 |
2014-09-16 |
0 |
Premium* |
|
|
Assembly Biosciences Inc |
ASMB |
See Remarks |
2019-03-29 |
117,500 |
2018-12-12 |
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
Beam Therapeutics Inc. |
BEAM |
Director |
2021-07-06 |
0 |
2021-06-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-07-06 |
4 |
AS |
$115.38 |
$315,263 |
D/D |
(2,614) |
0 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-07-06 |
4 |
OE |
$17.00 |
$44,438 |
D/D |
2,614 |
2,614 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-06-28 |
4 |
AS |
$105.37 |
$1,280,897 |
D/D |
(12,045) |
0 |
0 |
% |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-06-28 |
4 |
OE |
$17.00 |
$204,765 |
D/D |
12,045 |
12,045 |
0 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2021-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ASMB |
Assembly Biosciences Inc |
See Remarks |
• – – |
2019-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
117,500 |
0 |
- |
|
| ASMB |
Assembly Biosciences Inc |
See Remarks |
• – – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Financial Officer |
• – – |
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,500) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Financial Officer |
• – – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
10,500 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Financial Officer |
• – – |
2014-09-16 |
4 |
AS |
$61.30 |
$3,065,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Financial Officer |
• – – |
2014-09-16 |
4 |
OE |
$5.10 |
$255,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2009-12-21 |
4 |
S |
$8.36 |
$146,898 |
D/D |
(17,500) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2009-12-21 |
4 |
S |
$8.17 |
$677,862 |
D/D |
(82,500) |
17,500 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2009-12-21 |
4 |
OE |
$0.70 |
$70,000 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2008-08-21 |
4 |
OE |
$0.70 |
$5,781 |
D/D |
8,259 |
8,259 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2008-08-21 |
4 |
AS |
$12.00 |
$99,108 |
D/D |
(8,259) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2007-12-20 |
4 |
AS |
$14.05 |
$56,364 |
D/D |
(4,000) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2007-12-20 |
4 |
OE |
$0.70 |
$2,800 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2007-11-20 |
4 |
AS |
$14.50 |
$58,973 |
D/D |
(4,000) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CFO and Treasurer |
• – – |
2007-11-20 |
4 |
OE |
$0.70 |
$2,800 |
D/D |
4,000 |
4,000 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
